The clinical course and outcome of 55 fetuses with complete atrioventricular (A V) block detected prenatally were studied to identify factors that affect the natural history of this lesion. In 29 fetuses (53%) complete A V block was associated with complex structural heart defects, usually left atrial isomerism (n = 17) or discordant A V connection (n = 7). The other 26 fetuses had normal cardiac anatomy; in 19 cases the mother had connective tissue disease or tested positive for antinuclear antibodies. Six fetuses showed progression from sinus rhythm or second degree block to complete A V block.
however, was frequently associated with left atrial isomerism. In fetuses without left isomerism, mean atrial rate was not significantly different in surviving and nonsurviving fetuses (142 ± 8 vs.
144 ± 15 beats/min, p = 0.66), whereas ventricular rate remained different (64 ± 8 vs. 53 ± 8 beats/min, p < 0.001).
In four cases, transplacental treatment by administering sympathomimetic drugs to the mother was attempted. Although ventricular rate increased variably, only one of these four fetuses, which had no additional structural defect, survived. Effective forms of fetal therapy are not established. A postnatal permanent pacemaker was implanted in 13 neonates; 9 survived the neonatal period.
(J Am Coli CardioI1991;91: reviewed the pooled experience from three centers that perform prenatal cardiac diagnosis and treatment and studied the course and outcome of 55 fetuses with complete A V block seen over a 10 year period.
Methods
Study patients. From 1979 to 1989, fetal echocardiography was performed in 7,200 pregnant women for various indications at the medical centers of the University of Heidelberg, the University of California, San Francisco and Yale University, New Haven. Complete AV block was identified in 55 fetuses between 17 and 38 weeks' gestation. We reviewed their fetal ultrasound studies to confirm the diagnosis and to determine fetal heart rate and presence of associated structural cardiac lesions. In addition, we reviewed their medical records and autopsy and surgical reports to determine the perinatal course and outcome up to the end of the neonatal period.
UItrasonographic diagnosis. Echocardiographic evaluation was performed with use of several different scanners with 3 to 5 MHz transducers. The ultrasound devices were equipped with real-time guided M-mode echocardiography and. in recent years, with pulsed Doppler facilities. Fetal cardiac anatomy was examined with standard tomographic imaging techniques (12) .
Complete AV block was diagnosed when A V dissociation with a regular atrial rate exceeding a slow ventricular rate was present. Such A V dissociation was noted on a simultaneous M-mode recording of the atrial and ventricular wall movements or on pulsed Doppler tracings of left ventricular inflow and outflow signals (Fig. 1) . Atrial and ventricular SCHMIDT ET AL.
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FETAL COMPLETE ATRIOVENTRICULAR BLOCK rates were determined from these recordings by averaging the beat to beat intervals of 5 to 10 consecutive beats. The atrial and ventricular rates cited relate to the initial study that showed heart block.
Statistics. Values are given as mean values :±: SD. A chi-square test with the Yates correction was used to analyze the influence of associated structural heart defects, hydrops, maternal connective tissue disease or antinuclear antibodies and atrial and ventricular heart rate on neonatal outcome. The unpaired Student's t test was used to compare atrial and ventricular rates in surviving and nonsurviving fetuses; a p value < 0.05 was considered significant.
Results
Clinical and ultrasound findings (Table 1) . Almost all of the 55 women were referred for evaluation because a slow or irregular fetal heart rate was noted on routine obstetric examination; one woman was referred because of maternal diabetes mellitus and suspected fetal heart disease. The gestational age of the 55 fetuses at the time of definite diagnosis of complete A V block ranged from 17 to 38 weeks (median 26). Twenty-nine fetuses with complete AV block had associated structural cardiac defects, usually including left atrial isomerism (polysplenia syndrome, n = 17) or discordant A V connection (n = 7). The other 26 fetuses had no evidence of associated structural cardiac defects; 19 of these fetuses were carried by mothers who had manifested connective tissue disease or tested positive for antinuclear antibodies, most often Ro-(SS-A)-antibodies, and 7 mothers were healthy and had negative serologic findings. Ultrasound examination revealed hydrops in 22 fetuses. In three fetuses with left isomerism, one with A V discordance and two with normal cardiac anatomy, progression from either sinus rhythm or second degree block to complete A V block was observed.
Outcome (Table 2 ). Of the 55 pregnancies, 5 were terminated and 24 fetuses or neonates died; at the end of the neonatal period 26 fetuses with complete A V block were alive. Fetal or neonatal death was significantly related to the presence of associated structural heart defects (p < 0.001), hydrops (p < 0.001), an atrial rate ::;120 beats/min (p < 0.005) and a ventricular rate ::;55 beats/min (p < 0.001). In fetuses without structural heart defects, fetal or neonatal death was not related to the presence of maternal connective tissue disease or antinuclear antibodies.
Heart rates ( Table 2 ). Atrial rate ranged from 96 to 400 beats/min and ventricular rate from 40 to 80 beats/min. After exclusion of the terminated pregnancies and of the fetus that had atrial flutter, analysis of the heart rate in 49 fetuses revealed a high incidence of fetal or neonatal death if atrial rate was :S 120 beats/min or ventricular rate ::;55 beats/min. Mean atrial rate and mean ventricular rate were significantly higher in surviving than in non surviving fetuses (142 :±: 8 vs.
127 ± 21 beats/min, p < 0.002; 64 :±: 8 vs. 52 ± 8 beats/min, p < 0.001, respectively). Ventricular rate tended to remain *Excluding one fetus with atrial flutter and pregnancies that were terminated. A V = atrioventricular; CHD = congenital heart defect; T = terminated pregnancy.
within ± 5 beats/min during follow-up studies and tended to slow down further in fetuses that subsequently died.
When the atrial and ventricular rates were analyzed separately for fetuses with and without associated structllral defects it became apparent that a slower atrial rate was present only in fetuses with an associated structural defect (Fig. 2) . In particular, the fetuses with an associated structural defect that had left atrial isomerism had a slow atrial heart rate and later died. After exclusion of fetuses with left atrial isomerism, mean atrial rate was not significantly different between surviving and nonsurviving fetuses (142 ± 8 vs. 144 ± 15 beats/min, p = 0.66), whereas mean ventricular rate was still significantly higher in the surviving fetuses (64 ± 8 vs. 53 ± 8 beats/min, p < 0.001).
Treatment. Transplacental treatment of complete A V block was attempted in four fetuses; two had an associated structural heart defect with left atrial isomerism and three did not. In an attempt to increase fetal heart rate, the mother was given terbutaline (10 to 40 p,g/min intravenously, then maintained orally at 2.5 to 5 mg every 4 to 6 h), ritodrine (50 p,g/min intravenously, then maintained orally at 10 to 20 mg every 4 h) or isoproterenol (0.05 to 0.1 p,g/kg per min intravenously). This treatment caused an increase in fetal ventricular rate of 15% to 50%, but only one fetus, without an associated structural heart disease, survived to delivery. The mother of another fetus without an associated structural heart defect received dexamethasone (2 doses at 12 mg intramuscularly within 24 h) to prevent progression from second degree to complete A V block. This attempt failed, but the fetus survived with complete A V block.
Postnatal implantation of a permanent pacemaker was performed in 13 neonates, 6 with and 7 without an associated structural heart defect. Of these neonates with an implanted pacemaker, 9 (69%) were alive at the end of the neonatal period; only 2 of the 6 with a structural defect survived, but all 7 without an associated structural heart defect survived the neonatal period.
Discussion
Associated structural heart defects. Our study demonstrates that 29 (53%) of the 55 fetuses diagnosed as having complete A V block had an associated structural cardiac defect. Their prognosis was very poor; only 4 (14%) of these 29 fetuses survived the neonatal period. This finding is comparable with that of previous reports (7, 13) in smaller series of fetal complete A V block but is very different from reports on congenital AV block diagnosed after birth (1, 14) . In a large cooperative study (1) comprising 599 infants and children with congenital complete A V block, an associated structural cardiac defect was found in 30%; in a series reported more recently (4) , an associated cardiac defect was present in 39%. About 70% of these patients with complete A V block and structural heart defects were alive at long-term follow-up, and even among those who were symptomatic at birth, 58% survived (I). Eighteen fetuses in our series with an associated structural heart defect did not come to term, and it is likely that postnatal observation provides a limited perspective of the natural history.
Other associations with a poor prognosis in our study group with fetal complete A V block and an associated structural heart defect were the presence of nonimmune hydrops (18 fetuses) and left atrial isomerism (17 fetuses, 13 of which also had hydrops); none of these fetuses survived the neonatal period.
Left atrial isomerism or discordant A V connection was most often part of the structural cardiac defect (Table 1).
This finding is not surprising, because the association of complete AV block with left atrial isomerism (15) (16) (17) or with AV discordance (14,18) has been described in cases detected after birth. Fetuses with A V discordance had a slightly better prognosis; four of the seven fetuses in our series with a discordant A V connection survived. These 4 were also the survivors among 11 fetuses without evidence of hydrops, and the only survivors of all fetuses with associated struc- tural heart defects ( Table 2) . Therefore, a subset of fetuses with discordant A V connection, but no hydrops, may have the best prognosis among fetuses that have complete A V block and an associated structural heart defect.
Isolated complete A V block. The prognosis for fetuses with complete A V block but without additional structural heart defects was much better than for those with additional structural heart defects; 22 (85%) of the 26 fetuses survived the neonatal period, a rate similar to that reported (1) after birth, when about 90% of infants and children with isolated complete A V block were alive at long-term follow-up. Most of these fetuses were born to mothers who had either manifested connective tissue disease or tested positive for antinuclear antibodies. Role of maternal and fetal antibodies. Previous clinical observations (19, 20) had suggested that isolated congenital complete A V block occurs more frequently in children of mothers with lupus erythematosus or other connective tissue disorders. Autoantibodies, especially to the SS-A/Ro or SS-B/La antigens, have been found subsequently in mothers and their affected newborns (21) (22) (23) , and the deposition of such antibodies in fetal cardiac tissue has been demonstrated (24) (25) (26) , suggesting that antibodies and complete A V block are causally related. Although the overall risk of women with recognized lupus having a child with complete A V block appears to be low (27) , this risk increases considerably if anti-SS-A antibodies are present (28) . The neonatal outcome of these children, however, does not seem to be influenced by the presence of anti-SS-A antibodies, as was shown in a large postnatal study (28) . The findings in our fetal study group are comparablf' with data from these reports on patients after birth; thet"e is a high incidence of seropositive mothers among fetuses with isolated complete A V block, but their neonatal outcome is not influenced significantly by positive or negative maternal serologic findings.
We noted fetal hydrops less frequently in fetuses with isolated complete A V block than in fetuses with associated structural heart defects (15% vs. 61%). If present, however, fetal hydrops was a poor prognostic sign for the fetus with isolated complete A V block as well; all four hydropic fetuses with isolated complete A V block died before or at birth.
Fetal hydrops. Hydrops was the worst prognostic sign for a fetus with complete A V block, regardless of the presence or absence of an associated structural heart defect. Nonimmune fetal hydrops indicates profound cardiac failure (29) , which in the fetus with complete A V block most likely results from low cardiac output due to the structural cardiac lesion or slow heart rate, or both. Changes in heart rate have been shown to affect cardiac output considerably in fetal lambs (30) . Although the Frank-Starling mechanism is operative in the fetus, the ability to adapt to changes in preload and afterload is limited even in the normal fetal heart (31 ,32) . Adaptation to increasing demands on cardiac output may be further hindered by the complete dissociation of atrial and ventricular contractions in complete A V block. Atrial contraction contributes to a much larger extent to ventricular filling in the fetal heart than in the postnatal heart (33.34). In fetal lambs with induced complete A V block, dual chamber sequential pacing led to a much higher combined ventricular output than that achieved with ventricular pacing (34) .
Even discrete hemodynamic events such as diastolic A V valve regurgitation, which has been demonstrated in complete heart block postnatally (35) , may aggravate the increase in venous pressure and congestion in the fetal circulation. Increased venous pressure coupled with the low colloid osmotic pressure in the fetus may lead to subsequent fetal edema, as suggested by similar observations in severe fetal A V valve regurgitation without heart block (36) . Furthermore, the fetal heart with structural abnormalities that already impose a volume or pressure load may not be able to cope with the additional burden of the slow ventricular rate.
Effects of heart rate. A ventricular rate of <55 beats/min has been related to a poor outcome in children with complete AV block detected after birth (1). We observed a similar trend; only 3 of 21 fetuses with a ventricular rate ::;55 beats/min were alive at the end of the neonatal period, whereas 23 of 28 with a higher ventricular rate survived (Table 2) . Obviously, the fetus with complete AV block and a ventricular rate ::;55 beats/min is very likely to be stillborn; 17 of the 19 fetuses that had a slow ventdcular rate died spontaneously before birth or were born prematurely and died.
With respect to atrial rate, discrepant fihdings have been reported; Michaelsson and Engle (1) found that an atrial rate > 140 beats/min was associated with a poor outcome in infants and children with complete A V block. Serwer et al.
(0) stated that an atrial rate < 120 beats/min was indicative of impending fetal death in their study of 14 fetuses with complete A V block. Initially, our study appeared to support the latter view, because the surviving fetuses had a higher atrial rate than the nonsurviving fetuses. However, separate analysis of heart rates in fetuses with and without associated structural heart defects revealed that almost all fetuses with an atrial rate ::; 120 beats/min that died eventually had left atrial isomerism (Fig. 2) . Because the sinus node is a right atrial structure, it is absent or hypoplastic in left atrial isomerism (16) ; this may explain the slower atrial rate in fetuses with left isomerism. Most likely, therefore, the poor outcome of our fetuses with an atrial rate::; 120 beats/min is related to their structural cardiac lesion and left atrial isomerism, but not to the slow atrial rate itself. Accordingly, the ventricular but not the atrial rate was significantly different in surviving and non surviving fetuses when those with left atrial isomerism were excluded from the analysis. Serwer et al. (0) did not report the incidence of left atrial isomerism in their study group.
Progression of A V block. In six fetuses of our study group, sinus rhythm progressed to A V block or second degree block progressed to complete A V block. Four of these fetuses had an associated structural heart defect-left atrial isomerism in three, discordant AV connection in one-and two had normal cardiac anatomy. Although the number of patients is small, this observation is interesting with respect to developmental aspects of complete A V block. Evidently, the A V node and His bundle originate separately and fuse very early during fetal development (37) . Although some investigators (38) consider primary failure of fusion between atrial muscle and A V node or between A V node and His bundle the likely mechanisms causing complete A V block, others (39) suggest that secondary interruption of the A V conduction system by fibrous tissue may lead to complete A V block. The progression from normal or only partially blocked A V conduction to complete A V block that we observed in some cases favors the latter theory of secondary interruption of the conduction pathway. This is in SCHMIDT ET AL.
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FET AL COMPLETE ATRIOVENTRICULAR BLOCK accordance with reports from investigators (40, 41) who documented in fetuses without an associated structural heart defect that a normal ventricular rate up to 20 weeks of gestation preceded the onset of a slow ventricular rate due to complete AV block. Other mechanisms, however, may also be involved in the development of complete A V block.
Treatment. Several means of treating the hydropic fetus with complete A V block have been tried. Some investigators (40, 42) used the maternal or the direct fetal route for administration of adrenergic or anticholinergic drugs believed to increase the fetal heart rate; others attempted to reduce maternal autoantibodies by administration of corticosteroids (41, 43) or by additional plasmapheresis (41, 44) . Carpenter et al. (40) reported on the unsuccessful application of transuterine transthoracic fetal ventricular pacing in a 26 week old fetus after pharmacologic treatment had failed. The results of these treatment attempts are diverse; best results in terms of fetal survival may be achieved by the preventive steroid and plasmapheresis treatment in mothers with connective tissue disease or autoantibodies (41, 44) . We administered sympathomimetic drugs to four mothers; with terbutaline, the ventricular rate usually increased, but only one fetus without an additional structural defect survived. The effectiveness of these regimens has not been assessed in controlled trials.
Theoretically, fetal ventricular pacing is the most logical form of treatment. Permanent cardiac pacemakers were successfully implanted through a thoracotomy in fetal lambs (45) . Because surgery in the previable human fetus with otherwise untreatable disease may be feasible (46) , pacemaker implants in the human fetus may become an alternative treatment. Selection criteria for such treatment are unclear. Experimental data suggest that hydropic fetuses with complete AV block require AV sequential pacing (34) .
Postnatal cardiac pacing has been established as an effective mode of treating complete A V block in children with a slow ventricular rate (47) . In our study a pacemaker was placed postnatally in 13 infants in whom A V block was diagnosed prenatally. Despite adequate pacing, 4 of them died, and these 4 had complex structural heart defects that may have contributed to the adverse outcome. Particularly in a viable fetus with isolated complete A V block, early delivery and immediate postnatal pacing may be an alternative treatment if fetal hydrops begins to develop (42) .
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